13yr old after swimming in a pool presented with vomitings on the same day with fever with bulbar palsy with opthalmoplegia with ptosis on ventilator with normal sensorium

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"Naegleria fowleri" meningoencephalitis treatment

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
I now have comprehensive data to give a thorough, well-structured answer. Here is the full clinical analysis:

Clinical Analysis: 13-year-old with Fever, Vomiting, Bulbar Palsy, Ophthalmoplegia, Ptosis after Swimming

Most Likely Diagnosis: Primary Amoebic Meningoencephalitis (PAM)

Causative organism: Naegleria fowleri

Why PAM Fits This Presentation

FeatureThis PatientPAM
Age13 yearsMedian age 14 yrs (range 1 month–85 yrs)
ExposureSwimming poolSwimming in warm freshwater/poorly maintained pools
OnsetSame day2–15 day incubation (can be rapid)
FeverPresentUniversal — high fever
VomitingPresentNausea and vomiting — cardinal feature
Cranial nerve palsiesCN III/IV/VI (ptosis + ophthalmoplegia) + bulbarCN III, IV, VI palsies are common
SensoriumNormal (early)Initially preserved; progresses to coma
Ventilator-dependentPresentRapid respiratory compromise requiring ventilation
"After an incubation period of 2–15 days, severe headache, high fever, nausea, vomiting, and meningismus develop. Photophobia and palsies of the third, fourth, and sixth cranial nerves are common. Rapid progression to seizures and coma may follow. The prognosis is uniformly poor: most patients die within a week." — Harrison's Principles of Internal Medicine 22E, 2025
N. fowleri enters via the olfactory neuroepithelium following nasal inhalation of contaminated water, migrates along the olfactory nerve to the brain, bypasses the blood-brain barrier, and invokes a fulminant neutrophilic meningoencephalitis. Even a poorly maintained swimming pool is a recognized source — the CDC has documented PAM from chlorinated pools.

Differential Diagnosis

1. Botulism (important to consider — normal sensorium + cranial palsies)

  • Bilateral cranial nerve palsies (ptosis, ophthalmoplegia, bulbar = dysarthria/dysphagia) + descending flaccid paralysis + fully conscious patient is the classic botulism triad
  • Against it: Fever is NOT a feature of botulism; CSF is normal; no GI prodrome of toxin-type (unless wound/food)
  • Normal CSF protein distinguishes botulism from GBS

2. Miller Fisher Syndrome (GBS variant)

  • Triad: ophthalmoplegia + ataxia + areflexia
  • Can have bulbar weakness; can require ventilation
  • Against it: Fever is atypical; swimming pool context not relevant; usually follows a viral infection 1–3 weeks prior; CSF shows albuminocytologic dissociation (elevated protein, no cells)

3. Brainstem Encephalitis (Rhombencephalitis)

  • Listeria monocytogenes, Enterovirus 71, HSV-2 can cause brainstem involvement with cranial nerve palsies + fever
  • Consider: Enterovirus rhombencephalitis in children

4. Bacterial Meningitis with Cranial Nerve Involvement

  • CN VI palsy is most common in bacterial meningitis (elevated ICP)
  • Combined ophthalmoplegia + bulbar + fever: consider TB meningitis (basal meningitis)

5. Wernicke's Encephalopathy — ophthalmoplegia + ataxia, but no fever; unlikely in 13-year-old


Why the Sensorium is Normal (Key Feature)

In early PAM, sensorium is preserved. The brain-eating amoeba first produces a fulminant meningitic picture with cranial nerve palsies before cerebral involvement causes drowsiness and coma. This is also characteristic of botulism (fully conscious throughout). This preserved sensorium with cranial nerve deficits and fever most strongly points to PAM in this swimming pool context.

Investigations

TestExpected Finding in PAM
CSF wet mountMotile trophozoites — diagnostic
CSF cell countHigh WBC (up to 20,000/μL) — neutrophilic
CSF proteinElevated
CSF glucoseLow
CSF Gram stain/cultureNegative for bacteria
CSF PCR (CDC)Positive for N. fowleri
Brain MRIDiffuse enhancement, particularly olfactory bulbs, basal ganglia
SerologyNot useful (antibodies found in healthy adults)
Critical point: CSF should be examined immediately as a fresh wet preparation — trophozoites (10–35 μm) are motile and can be seen on direct microscopy. Refrigeration kills them. Contact CDC Emergency Operations at (770) 488-7100 immediately.

Treatment (Medical Emergency)

PAM has a >97% fatality rate, but survivors have been reported with early aggressive therapy:

Combination Regimen (All survivors included these agents):

DrugRole
Miltefosine (Impavido)Most critical — only drug shown in all 7 worldwide survivors; alkylphosphocholine amoebicidal
Amphotericin B liposomal (IV + intrathecal)Primary amoebicidal
FluconazoleSynergistic
AzithromycinSynergistic
RifampinSynergistic
DexamethasoneReduce neuroinflammation

Adjunctive:

  • Therapeutic hypothermia — associated with better outcomes in survivors
  • Aggressive ICP management
  • Mechanical ventilation (already on)
"All seven survivors among reported worldwide cases (381) included miltefosine as well as the five drugs above. Early diagnosis, prompt combination therapy including miltefosine, and aggressive management of neurologic complications, including therapeutic hypothermia, are important factors in better outcomes." — Harrison's 22E

Summary Algorithm

13yo + fever + vomiting + swimming pool + CN III/IV/VI palsies + bulbar palsy + ventilator + NORMAL SENSORIUM
         │
         ↓
PRIMARY AMOEBIC MENINGOENCEPHALITIS (Naegleria fowleri) — MOST LIKELY
         │
         ↓
URGENT: Fresh CSF wet mount for motile trophozoites
         + CDC PCR (call CDC immediately)
         │
         ↓
START EMPIRIC TREATMENT WITHOUT WAITING:
Miltefosine + Liposomal AmB + Fluconazole + Azithromycin + Rifampin + Dexamethasone
+ Therapeutic hypothermia

Prognosis

Prognosis is grave — mortality >97% even with treatment. Only 7 survivors have been documented worldwide (out of 381 reported global cases as of 2022). Survival correlates with:
  • Early suspicion and diagnosis
  • Prompt initiation of miltefosine-containing combination therapy
  • Aggressive ICU/neurological management
Recent PubMed evidence (Hall AD et al., 2024, PMID 38182931 — review of successfully treated cases) confirms miltefosine as central to the rare survivors.

Sources: Harrison's Principles of Internal Medicine 22E (2025); Bradley & Daroff's Neurology in Clinical Practice; Medical Microbiology 9e; Tintinalli's Emergency Medicine; Red Book 2021

Without meningismus

Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The absence of meningismus is a pivotal negative that fundamentally redirects the diagnosis. Here is the revised analysis:

Revised Diagnosis: No Meningismus Changes Everything

The full syndrome now is: Fever + Vomiting + Bulbar palsy + Ophthalmoplegia + Ptosis + Ventilator-dependent + Normal sensorium + NO neck stiffness/meningism
This combination — cranial nerve palsies descending to bulbar involvement + respiratory failure + intact consciousness + NO meningeal signs — is the hallmark of a neuromuscular junction (NMJ) disorder, most specifically:

#1 Diagnosis: Wound/Water-Associated Botulism

Why This Is Now the Leading Diagnosis

FeatureThis PatientBotulism
PtosisClassic — first cranial nerve sign
Ophthalmoplegia (CN III/IV/VI)Characteristic bilateral cranial palsies
Bulbar palsy (dysarthria, dysphagia)Descending cranial → bulbar pattern
Normal sensorium (fully awake)Brain is unaffected — pathognomonic
Ventilator requiredRespiratory muscle paralysis
No meningismusNo CNS inflammation whatsoever
VomitingAutonomic involvement; also foodborne prodrome
Swimming poolWound botulism from water/soil contact
"The distinct syndrome of bilateral cranial palsies and descending flaccid paralysis in a fully conscious patient should render the diagnosis of botulism straightforward." — Harrison's Principles of Internal Medicine 22E
"No fever or other signs of infection occur [in classic botulism]. A slower moving form of the disease occurs when the toxin is produced endogenously in the intestinal tract or a wound." — Sherris & Ryan's Medical Microbiology 8e

The Fever — How Does It Fit?

Fever is not typical of foodborne botulism (preformed toxin). However, wound botulism — where C. botulinum infects a wound (or skin abrasion from a pool/lake floor) and produces toxin in situ — CAN produce fever due to the wound infection itself. A 13-year-old swimming could sustain minor abrasions, and pool environments can be contaminated with C. botulinum spores from soil.
Wound botulism with secondary wound infection = fever + all neurological features + no meningismus.

Pathophysiology of the Neurological Pattern

C. botulinum toxin (metalloproteinase)
         ↓
Cleaves SNARE proteins at presynaptic membrane
         ↓
Blocks ACh release at NMJ
         ↓
Descending flaccid paralysis:

  CRANIAL NERVES FIRST (CN III/IV/VI → ptosis + ophthalmoplegia)
         ↓
  BULBAR (CN IX/X/XII → dysphagia, dysarthria, dysphonia)
         ↓
  RESPIRATORY MUSCLES (diaphragm + intercostals → ventilator)
         ↓
  LIMB WEAKNESS (late)

  *** Brain unaffected → Normal sensorium throughout ***
  *** No meningeal inflammation → No neck stiffness ***

Differential Diagnosis (with No Meningismus)

1. Wound Botulism ← Most Likely

  • Swimming pool abrasion → C. botulinum spore germination → in situ toxin → descending NMJ blockade
  • Fever from wound infection
  • Normal CSF

2. Miller Fisher Syndrome (GBS variant)

  • Triad: ophthalmoplegia + ataxia + areflexia
  • No fever typically; can have bulbar; CSF shows elevated protein (albuminocytologic dissociation)
  • Anti-GQ1b antibodies positive
  • Against it: Fever is atypical; can have some overlap but no meningismus fits; ataxia is the key feature (check for it)

3. Foodborne Botulism

  • If the child consumed contaminated food around the time of swimming
  • Vomiting fits the gastrointestinal prodrome (nausea, vomiting, cramping precede neurological symptoms by hours)
  • No fever expected — but possible co-existing illness

4. Myasthenia Gravis (MG) Crisis

  • Ptosis + ophthalmoplegia + bulbar + respiratory failure
  • Against: Fever not a feature; no exposure history; fatigability worse with exertion; usually chronic history; Tensilon test positive

5. Bickerstaff Brainstem Encephalitis

  • Ophthalmoplegia + ataxia + hyperreflexia + impaired consciousness
  • Against: Sensorium should be impaired; no fever typically

6. Enterovirus 71 Rhombencephalitis

  • Children, fever, brainstem involvement, respiratory failure
  • But: usually has altered sensorium, myoclonus, autonomic instability; typically preceded by hand-foot-mouth disease

Investigations

TestExpected in Wound Botulism
Serum botulinum toxin assay (mouse bioassay)Positive — gold standard
Wound cultureC. botulinum growth under anaerobic conditions
CSFNormal — protein, glucose, cells all normal
EMG/NCSFacilitating pattern on rapid repetitive stimulation (incremental response), reduced CMAP amplitude
CT/MRI brainNormal
Acetylcholine receptor antibodiesNegative (rules out MG)
Anti-GQ1b antibodiesNegative (rules out MFS)
Edrophonium (Tensilon) testNegative in botulism
Key CSF distinction:
  • Botulism → Normal CSF
  • GBS/MFS → Elevated protein, no cells
  • PAM → Neutrophilic pleocytosis, low glucose
  • Bacterial meningitis → Neutrophilic pleocytosis + positive culture

Treatment

Wound Botulism:

  1. Heptavalent Botulinum Antitoxin (HBAT) — give immediately, before lab confirmation; binds circulating free toxin (cannot reverse bound toxin)
  2. Wound debridement + Penicillin G or Metronidazole (to eliminate C. botulinum from wound)
  3. Mechanical ventilation — may be required for weeks to months
  4. Supportive ICU care — recovery depends on new NMJ sprouting (weeks to months)
  5. Do NOT give aminoglycosides — worsen NMJ blockade
  6. Contact CDC (Emergency Operations: 770-488-7100) for antitoxin release

Summary

Without meningismus, PAM drops significantly in likelihood (it characteristically presents like bacterial meningitis with meningeal signs). The clinical triad of:
Descending cranial nerve palsies (ptosis → ophthalmoplegia → bulbar) + respiratory failure requiring ventilation + fully conscious patient + NO meningism
...is the signature of botulism until proven otherwise — specifically wound botulism in the context of swimming pool exposure with fever.
The normal sensorium with no meningismus is the single most important negative that points the diagnosis away from meningitis/encephalitis and squarely toward a presynaptic NMJ toxin-mediated disorder.

First is bulbar

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"pharyngeal-cervical-brachial" variant Guillain-Barre syndrome

Reading File
Reading Article

PMID: 25072194

Now the picture is crystal clear. Here is the revised, refined analysis:

Revised Analysis: Bulbar Palsy First, Then Ophthalmoplegia + Ptosis

The Sequence Is the Diagnosis

Bulbar (CN IX/X/XII) FIRST
        ↓
Ophthalmoplegia + Ptosis (CN III/IV/VI) NEXT
        ↓
Respiratory failure (ventilator)
        ↓
Normal sensorium | No meningismus | Fever | Post-swimming
This ascending cranial nerve pattern — starting low (bulbar) and moving up (ocular) — is the inverse of botulism and points squarely to:

#1 Diagnosis: Miller Fisher Syndrome / GBS Overlap (Pharyngeal-Cervical-Brachial variant or MFS-GBS overlap)

Specifically: GBS with severe bulbar and facial/cranial nerve paralysis, or the MFS-GBS overlap syndrome

Why

Harrison's 22E explicitly identifies this GBS subtype:
"GBS with severe bulbar and facial paralysis, sometimes associated with antecedent cytomegalovirus (CMV) infection and anti-GM2 antibodies" — as a regional GBS variant
And the Wakerley/Yuki 2014 classification (Nature Reviews Neurology, PMID 25072194) defines:
  • Pharyngeal-cervical-brachial (PCB) weakness — a localized GBS form presenting with oropharyngeal, neck, and shoulder weakness (bulbar first), which can extend to involve ocular muscles
  • MFS-GBS overlap — begins with ophthalmoplegia/ataxia then develops limb/bulbar weakness
  • Bickerstaff Brainstem Encephalitis (BBE) — ophthalmoplegia + ataxia + impaired consciousness (against this here as sensorium is normal)
The PCB variant is particularly compelling:
  • Starts with dysphagia, dysarthria (bulbar = CN IX/X/XII)
  • Progresses upward to involve CN III/IV/VI (ophthalmoplegia, ptosis)
  • Can progress to respiratory failure requiring ventilation
  • Normal sensorium throughout
  • Associated with anti-GT1a antibodies (not GQ1b, which is MFS)

Differential Framework by Cranial Nerve Sequence

PatternDirectionDiagnosis
CN III/IV/VI → Bulbar → LimbsDescendingBotulism
Bulbar → CN III/IV/VI → LimbsAscending / caudal→rostralPCB-GBS, MFS-GBS overlap
Bulbar + CN III/IV/VI simultaneouslyDiffuse brainstemBrainstem encephalitis (BBE, rhombencephalitis)
Bulbar + CN III/IV/VI + altered consciousnessBrainstemBickerstaff's

Full Differential (Reordered by Fit)

1. Pharyngeal-Cervical-Brachial (PCB) variant of GBS ← Top Diagnosis

  • Bulbar weakness first (dysphagia, dysarthria, nasal voice)
  • Extends to CN III/IV/VI (ophthalmoplegia, ptosis)
  • Respiratory failure in severe cases
  • Normal sensorium, no meningismus
  • CSF: albuminocytologic dissociation (elevated protein, no cells)
  • Anti-GT1a IgG antibodies — highly specific for PCB
  • Trigger: swimming pool → possible enteric infection (Campylobacter, CMV) 1–3 weeks prior

2. MFS-GBS Overlap Syndrome

  • Classic MFS (ophthalmoplegia + ataxia + areflexia) with additional bulbar/limb weakness
  • Can begin with bulbar if overlap is significant
  • Anti-GQ1b IgG (present in >85% MFS cases)
  • Fever uncommon but possible with antecedent infection

3. Bickerstaff Brainstem Encephalitis (BBE)

  • Ophthalmoplegia + ataxia + impaired/fluctuating consciousness
  • Anti-GQ1b positive (same spectrum as MFS)
  • Against here: sensorium is described as normal
  • MRI may show brainstem hyperintensities

4. Botulism (Wound)

  • Now less likely given bulbar-first sequence (botulism is strictly cranial-first descending: CN III/IV/VI → bulbar)
  • However, wound botulism with a scratch from pool floor remains possible if one argues the sequence was misidentified

5. Listeria Rhombencephalitis

  • Fever + brainstem involvement (CN palsies + bulbar)
  • Usually has altered sensorium or cerebellar signs
  • CSF typically abnormal
  • Against: normal sensorium, no meningismus

Why Swimming Pool is Still Relevant

The pool provides the antecedent infection trigger for an immune-mediated neuropathy (GBS/PCB/MFS):
  • Pool water → swallowing of pool water → enteric infection (Campylobacter jejuni, CMV, hepatitis E)
  • Incubation 1–3 weeks → molecular mimicry → anti-ganglioside antibodies → cranial nerve demyelination
  • The same-day onset suggests either a very rapid post-infectious response or the swimming event itself is coincidental while the antibody-mediated attack was already underway

Investigations

TestExpected Finding
CSFElevated protein, NO pleocytosis (albuminocytologic dissociation)
Anti-GT1a IgGPositive → confirms PCB variant
Anti-GQ1b IgGPositive → confirms MFS/BBE
Anti-GM2 IgGPositive → GBS with bulbar/cranial involvement post-CMV
Nerve conduction studiesDemyelinating pattern (prolonged distal latencies, reduced conduction velocity) or axonal
MRI brain/brainstemNormal (PCB/MFS) or brainstem T2 hyperintensity (BBE)
Stool/serologyCampylobacter jejuni, CMV, EBV
EMGReduced CMAP, absent/reduced F waves

Treatment

Since the likely diagnosis is immune-mediated (GBS spectrum):
  1. IVIg (Intravenous immunoglobulin) — 2 g/kg over 5 days — first line
  2. Plasmapheresis — equally effective alternative; 4–6 exchanges
  3. Do NOT use steroids — not beneficial in GBS and may worsen
  4. Mechanical ventilation — already established; monitor FVC, NIF
  5. Supportive care: DVT prophylaxis, nutrition, dysautonomia monitoring, pain management

Key Teaching Point

Bulbar-first then ophthalmoplegia = ascending cranial nerve pattern = PCB-GBS or MFS-GBS overlap
Ophthalmoplegia-first then bulbar = descending pattern = Botulism
The direction of cranial nerve involvement is the single most important localizing clue in this presentation.
The swimming pool provides the antigenic trigger (enteric infection) for an immune-mediated post-infectious cranial polyneuropathy — not direct CNS invasion as in PAM, which has been effectively excluded by the absence of meningismus and the ascending cranial nerve sequence.

Palatal tremors vs palatal myoclonus

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent, comprehensive data from three major neurology textbooks. Here is the full comparison:

Palatal Tremor vs Palatal Myoclonus

Terminology First

These two terms refer to the same physical phenomenon (rhythmic palatal movements) but from different conceptual frameworks:
  • "Palatal myoclonus" — older term; used because the movements appeared myoclonic
  • "Palatal tremor" — current preferred term; reclassified because of persistent rhythmicity (tremors are rhythmic; myoclonus is typically arrhythmic)
However, the distinction matters mechanistically:
  • True tremor = oscillatory movement from synchronous or alternating contractions of antagonist muscles
  • True myoclonus = rhythmic contractions of agonist muscles only (uniphasic)
Palatal movements are agonist-only contractions → technically myoclonus by mechanism, but tremor by pattern. Both terms remain in use.

The Two Subtypes: The Critical Clinical Distinction

FeatureEssential Palatal Tremor (EPT)Symptomatic Palatal Tremor (SPT)
Old nameEssential palatal myoclonusSymptomatic palatal myoclonus
Muscle involvedTensor veli palatini (CN V₃)Levator veli palatini (CN X)
Ear clickPresent — characteristic (opens Eustachian tube)❌ Absent
Persists during sleepDisappears with sleepPersists during sleep
Associated movementsPalate onlyPalate + pharynx + face + eyes + diaphragm + neck/shoulders
Pendular nystagmus❌ Absent✅ May be present (synchronized)
MRI brainNormal — no lesionInferior olivary pseudohypertrophy (hallmark)
Brainstem lesionNone✅ Central tegmental tract lesion
Guillain-Mollaret triangleNot involvedDisrupted — key pathology
EtiologyUnknown / functionalVascular, demyelinating, neoplastic, traumatic
FrequencyVariable; often higherVariable but tends to be fixed
Functional/psychogenicMore likelyLess likely
Onset after injuryMonths of latency before tremor appears

Pathoanatomy of Symptomatic Palatal Tremor

The key structure is the Guillain-Mollaret Triangle (dentato-rubro-olivary pathway):
Contralateral Dentate Nucleus (cerebellum)
              ↓  (superior cerebellar peduncle / brachium conjunctivum)
Ipsilateral Red Nucleus (midbrain)
              ↓  (Central Tegmental Tract — CTT)
Ipsilateral Inferior Olivary Nucleus (medulla)
              ↓  (inferior cerebellar peduncle / climbing fibers)
Back to Dentate Nucleus
Lesion of the CTT (or anywhere in the triangle) → disinhibits the inferior olivary nucleus → olive undergoes pseudohypertrophy (hypertrophic olivary degeneration, HOD) → rhythmic olivary discharges → palatal tremor
With unilateral palatal tremor → it is the contralateral olive that enlarges (because the CTT crosses: lesion on one side → contralateral olive disinhibited)

MRI in SPT: Hypertrophic Olivary Degeneration (HOD)

  • T2/FLAIR: hyperintensity in inferior olive
  • Enlargement of olive (not atrophy — hence "hypertrophy")
  • Appears months after the causative lesion
  • May eventually regress over years

Quick Comparison Summary

Essential (EPT)Symptomatic (SPT)
Ear click✅ Yes❌ No
SleepDisappearsPersists
MuscleTensor veli palatiniLevator veli palatini
MRINormalOlivary pseudohypertrophy
CauseUnknownGuillain-Mollaret triangle lesion
Other movementsNoYes (eyes, face, diaphragm)

Associated Syndromes of SPT

  1. Oculopalatal myoclonus
    • Lateral form: jerky nystagmoid eye movements + oblique/rotatory components + lateralized palatal myoclonus (unilateral lesion)
    • Midline form: vertical pendular eye movements + bilateral symmetric palatal myoclonus
  2. Progressive Ataxia and Palatal Tremor (PAPT)
    • Low-frequency palatal tremor + progressive cerebellar degeneration + vertical nystagmus + internuclear ophthalmoplegia
    • Associated with Alexander disease, mitochondrial disorders, POLG mutations
    • Familial PAPT: brainstem/cervical cord atrophy, NO olivary pseudohypertrophy
  3. Whipple disease — oculomasticatory myorhythmia (masseter contractions + pendular ocular convergence; analogous phenomenon)

Treatment

AgentUse
GabapentinBest evidence; "dramatic effect" in some cases
Clonazepam0.25–0.5 mg → up to 6 mg/day
Sodium valproate250 mg → up to 1000 mg/day
Tetrabenazine / HaloperidolOccasionally helpful
Botulinum toxin (local injection)Modest relief; best for ear click in EPT
"Selective injection of the palatal muscles with botulinum toxin, while technically demanding, affords modest relief; it is particularly helpful in eliminating the bothersome ear clicking." — Adams & Victor's Neurology 12e

Memory Hook

Essential = Ear click, Extinguished in sleep, Extra-normal MRI, Etiologically unknown
Symptomatic = Sleep-persistent, Synchronized with nystagmus, Striking olivary hypertrophy, Secondary to Guillain-Mollaret triangle lesion
Adams & Victor's Principles of Neurology 12e; Bradley & Daroff's Neurology in Clinical Practice; Localization in Clinical Neurology 8e

Rhombencephalitis

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have all the data needed for a comprehensive answer.

Rhombencephalitis

Definition

Rhombencephalitis = inflammation of the rhombencephalon (hindbrain) — encompassing the brainstem (pons + medulla) and cerebellum. The term is used when encephalitis is anatomically restricted to these posterior fossa structures, as opposed to diffuse encephalitis affecting the whole brain.
The rhombencephalon is so named because the embryological fourth ventricle has a rhomboid (diamond) shape in dorsal view.

Clinical Syndrome

The clinical features reflect the anatomy — all structures of the posterior fossa:
Structure InvolvedClinical Features
PonsCN V (facial sensory loss), CN VI (lateral gaze palsy), CN VII (facial palsy), CN VIII (hearing, vertigo), long tract signs
MedullaCN IX/X (bulbar palsy — dysphagia, dysarthria, dysphonia), CN XII (tongue weakness), respiratory failure
CerebellumAtaxia (gait, limb), dysmetria, nystagmus
Midbrain (if involved)CN III/IV palsy, altered consciousness
General brainstemDiplopia, internuclear ophthalmoplegia, autonomic instability

Characteristic Biphasic Course (especially Listeria)

  1. Phase 1 (days 1–5): Fever, headache, nausea, vomiting — prodromal
  2. Phase 2 (days 5–10): Asymmetric cranial nerve palsies, cerebellar signs, long-tract signs, respiratory failure

Causes — Classified

Infectious

Bacterial

OrganismNotes
Listeria monocytogenesClassic cause — "rhombencephalitis" is almost synonymous with Listeria; predilects brainstem; asymmetric cranial nerve palsies; CSF often mildly abnormal or even normal; MRI shows brainstem T2 signal; meningeal signs in only 50%
Burkholderia pseudomalleiMelioidosis — similar to Listeria; endemic in India/Southeast Asia; multiple small abscesses in cerebellum and white matter
Mycobacterium tuberculosisBasal meningitis → brainstem involvement by exudate; cranial nerve palsies common
BrucellaNeurobrucellosis; chronic form
Treponema pallidumNeurosyphilis

Viral

VirusNotes
Enterovirus 71 (EV71)Children; follows hand-foot-mouth disease; brainstem encephalitis with myoclonic jerks + limb trembling; MRI: brainstem lesions; can progress to pulmonary edema/hemorrhage; most deaths in children ≤5 years
HSV-1 / HSV-2Usually temporal lobe but brainstem forms occur; recurrent brainstem encephalitis described with HSV-2
EBV, CMVPost-infectious; immunocompromised
RabiesBrainstem + spinal cord syndromes
Tick-borne encephalitis virusBrainstem/cerebellar involvement
West Nile VirusBrainstem encephalitis, flaccid paralysis
SARS-CoV-2Rare brainstem involvement

Fungal / Parasitic

OrganismNotes
CryptococcusBasilar meningitis → brainstem
AspergillusAngioinvasive; immunocompromised

Autoimmune / Para-infectious

EntityKey Features
Bickerstaff Brainstem Encephalitis (BBE)Ophthalmoplegia + ataxia + impaired consciousness (distinguishes from MFS); anti-GQ1b antibodies; MRI: T2 brainstem/thalamic hyperintensity or normal; treat as GBS spectrum (IVIg/plasma exchange)
CLIPPERSChronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids; subacute ataxia, diplopia, dysarthria; MRI: punctate gadolinium enhancement in pons/cerebellum; responds dramatically to steroids
Anti-NMDAR encephalitisUsually limbic but brainstem forms
NeurosarcoidosisCranial nerve palsies, hypothalamic involvement
CNS vasculitis
Multiple sclerosisBrainstem demyelinating plaques
ParaneoplasticAnti-Hu, anti-Ri (brainstem/cerebellar)

Key Organism Comparison: Listeria vs Enterovirus 71

FeatureListeria RhombencephalitisEV71 Rhombencephalitis
AgeElderly, immunocompromised, neonatesYoung children (≤5 years)
Preceding illnessNone / subtle GIHFMD (hand-foot-mouth disease)
Onset patternBiphasic — prodrome then CN palsiesAcute
CN palsiesAsymmetric, multiplePresent
Myoclonus/tremorLess typical✅ Characteristic — myoclonic jerks, limb trembling
Autonomic stormLess prominent✅ Common — tachycardia, hypertension
CSFMild pleocytosis or normalMild lymphocytic pleocytosis
MRIT2 brainstem lesionsBrainstem, dorsal pons/medulla lesions
Blood culturesPositive in >75%Negative
TreatmentAmpicillin + GentamicinSupportive
Mortality~30%High in severe cases

Bickerstaff Brainstem Encephalitis — Special Status

BBE occupies the interface between infectious rhombencephalitis and immune-mediated brainstem disease:
  • Preceded by systemic viral infection
  • Ophthalmoplegia + ataxia + altered consciousness (consciousness = key differentiator from MFS)
  • Anti-GQ1b IgG antibodies — same spectrum as Miller Fisher Syndrome
  • MRI: T2 hyperintensity in brainstem, cerebellum, thalamus — or normal
  • CSF: elevated protein, no cells (same as GBS/MFS)
  • Treatment: IVIg or plasmapheresis (as for GBS)
  • BBE + limb weakness = MFS-GBS overlap
"A brainstem disorder often confused with infection is Bickerstaff's brainstem encephalitis. Patients with this disorder have often had a preceding systemic viral infection, then acutely develop ataxia, ophthalmoplegia, long-tract signs, and alterations of consciousness including coma." — Plum & Posner's Diagnosis and Treatment of Stupor and Coma

Investigations

TestSignificance
MRI brain (FLAIR/T2/DWI)T2 hyperintensity in brainstem/cerebellum; always first
CSFCell count, protein, glucose, culture, PCR (HSV, EV, CMV)
Blood cultures × 3Positive in >75% of Listeriado before antibiotics
Anti-GQ1b antibodiesBBE / MFS
Anti-GT1a antibodiesPCB-GBS variant
EV71 PCRThroat swab, stool, CSF
Listeria PCRCSF or blood
Brucella serologyEndemic areas

Treatment by Etiology

CauseTreatment
ListeriaAmpicillin 2g IV q4h + Gentamicin (penicillin allergy: TMP-SMX)
Burkholderia (Melioidosis)Ceftazidime or meropenem → maintenance cotrimoxazole
HSVAcyclovir 10mg/kg IV q8h
EV71Supportive; milrinone for autonomic storm
BBE / GBS spectrumIVIg 2g/kg over 5 days or plasmapheresis
CLIPPERSHigh-dose corticosteroids → immunosuppression maintenance
TBAnti-tubercular therapy + steroids

Summary Framework

RHOMBENCEPHALITIS
       │
       ├─ INFECTIOUS
       │      ├─ Bacterial: Listeria ★ (classic), Melioidosis, TB, Brucella
       │      ├─ Viral: Enterovirus 71 ★ (children), HSV-2, Rabies, Tick-borne
       │      └─ Fungal: Cryptococcus, Aspergillus
       │
       ├─ AUTOIMMUNE / PARA-INFECTIOUS
       │      ├─ Bickerstaff Brainstem Encephalitis (anti-GQ1b) ★
       │      ├─ CLIPPERS (pontine perivascular)
       │      ├─ Paraneoplastic (anti-Hu, anti-Ri)
       │      └─ MS / neurosarcoidosis
       │
       └─ EMPIRIC APPROACH (while awaiting results)
              ├─ Cover Listeria: Ampicillin + Gentamicin
              ├─ Cover HSV: Acyclovir
              └─ Consider IVIg if anti-GQ1b pending (BBE)
Sources: Adams & Victor's Principles of Neurology 12e; Bradley & Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E; Plum & Posner's Diagnosis and Treatment of Stupor and Coma; Localization in Clinical Neurology 8e

Generalised dystonia in 20yr old from 5 years

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive data. Let me synthesize the full answer.

Generalised Dystonia in a 20-Year-Old (Onset at Age 15)

Clinical Context

  • Age of onset: 15 years (adolescent-onset)
  • Current age: 20 years
  • Duration: 5 years, progressive
  • Distribution: Generalised
This profile — adolescent-onset, generalised, progressive over years — places the patient in a specific diagnostic category that differs fundamentally from adult-onset focal dystonias.

Classification Framework (Consensus 2013 — Two-Axis System)

Axis I: Clinical Characteristics

FeatureThis Patient
Age at onsetAdolescence (13–20 years)
Body distributionGeneralised
Temporal patternProgressive (5 years)
VariabilityPersistent

Axis II: Etiology

CategoryExamples relevant here
InheritedDYT1, DYT2, DYT5, DYT6, DYT17, Wilson disease, PKAN
AcquiredPerinatal injury, drugs, infection, vascular, psychogenic
IdiopathicNo structural or degenerative pathology found
Key rule: In a young patient with generalised dystonia, always rule out treatable/secondary causes first before labelling as primary/genetic.

Priority Diagnosis: Wilson Disease ← Must Exclude First

Wilson disease (hepatolenticular degeneration) is the single most important diagnosis to exclude in any young patient with generalised dystonia because:
  1. It is treatable — delay causes irreversible neurological damage
  2. It presents exactly in this age group (5–35 years, peak 2nd decade)
  3. Neurological Wilson's = basal ganglia → generalised dystonia is a cardinal feature

Wilson Disease Features

  • Autosomal recessive (ATP7B gene, chromosome 13)
  • Copper accumulates in basal ganglia (especially putamen), liver, cornea
  • Neurological forms: dystonia (most common), tremor, dysarthria, dysphagia, parkinsonism, psychiatric symptoms
  • Kayser-Fleischer rings — golden-brown corneal deposits (slit-lamp examination)
  • Investigations: Serum ceruloplasmin ↓, 24-hr urinary copper ↑, serum copper ↓, slit-lamp KF rings, MRI ("face of giant panda" sign in midbrain)
  • Treatment: D-penicillamine, trientine, zinc salts — dramatic improvement if early

Differential Diagnosis: Generalised Dystonia, Adolescent Onset

1. Primary (Isolated) Genetic Dystonias

Gene/DYTNameInheritanceOnsetFeatures
DYT1 / TOR1AOppenheim dystonia (Early-onset primary torsion dystonia)AD (30% penetrance)6–12 yrs (can extend to adolescence)Starts in one foot/leg while walking → spreads to generalised; Chr 9q; Torsin A protein; no cognitive/intellectual involvement
DYT2AR primary torsion dystoniaARChildhood–adolescenceSimilar to DYT1; consanguineous families
DYT6 / THAP1Adolescent-onset mixed torsion dystoniaADAdolescenceUpper limb or cranial onset; dysphonia prominent; German-Mennonite origin
DYT17Adolescent-onset AR torsion dystoniaARAdolescenceRare
DYT1 is the most common inherited generalised dystonia. It begins in one limb (usually a leg/foot during walking), progresses over years to become generalised. Adolescent onset at 15 is within range.

2. Heredodegenerative Diseases Causing Generalised Dystonia

DiseaseKey FeatureTest
Wilson diseaseLiver + neuro + KF ringsCeruloplasmin, 24hr urine Cu, MRI
PKAN (NBIA type 1)"Eye of the tiger" MRI sign (GPi); PANK2 mutation; ARMRI brain (T2 GPi hypointensity with central hyperintensity)
NeuroacanthocytosisOrolingual dystonia, chorea, self-mutilation, areflexiaBlood film (acanthocytes), VPS13A gene
Huntington disease (juvenile)Akinetic-rigid or dystonic form; cognitive declineCAG repeat ≥55; family history
DRPLAAtaxia + myoclonus + dystonia + dementiaGenetic testing
GM1/GM2 gangliosidosisCherry-red spot, cognitive declineEnzyme assay
Metachromatic leukodystrophyWhite matter disease, MRI periventricular changesArylsulfatase A
Niemann-Pick CVertical supranuclear gaze palsy, ataxiaFilipin staining, NPC1/2
Lesch-Nyhan syndromeSelf-mutilation, hyperuricaemia (males only)HPRT enzyme activity

3. Dopa-Responsive Dystonia (DRD) — DYT5 / Segawa Syndrome

Cannot miss this — entirely treatable with levodopa:
  • GCH1 gene (autosomal dominant) or TH gene (AR)
  • Onset in childhood/adolescence, lower limb dystonia initially
  • Diurnal variation — symptoms worse in evening, better in morning after sleep (pathognomonic)
  • May have parkinsonism features
  • Levodopa trial: dramatic and sustained response at low doses
  • A levodopa trial should be performed in every young-onset generalised dystonia patient before any other diagnosis is accepted

4. Neurodegeneration with Brain Iron Accumulation (NBIA)

TypeGeneHallmark
PKAN (NBIA-1)PANK2"Eye of the tiger" sign on T2 MRI in globus pallidus
MPANC19orf12
BPANWDR45X-linked; females; regression then parkinsonism
FA2HFatty acid hydroxylase
PKAN: onset in childhood/adolescence, generalised dystonia + rigidity, oromandibular dystonia, retinal degeneration (in classic form), acanthocytosis.

5. Biotin-Responsive Basal Ganglia Disease (BBGD)

  • SLC19A3 mutation; AR
  • Episodic encephalopathy triggered by febrile illness → dystonia, dysarthria, dysphagia, ophthalmoplegia
  • MRI: bilateral caudate + putaminal lesions
  • Responds to biotin + thiamine — treatable

Investigations — Stepwise Approach

Step 1: Mandatory Screening (Never Skip)

TestTarget
MRI brain (T1, T2, FLAIR, SWI)Structural/degenerative, iron (PKAN), Wilson changes
Serum ceruloplasminWilson disease
24-hr urinary copperWilson disease
Slit-lamp examinationKayser-Fleischer rings (Wilson)
Liver function testsWilson (hepatic involvement)
Levodopa trialDRD — must be tried in ALL young-onset dystonia

Step 2: If Step 1 Negative

TestTarget
Serum copperWilson
Blood film (acanthocytes)Neuroacanthocytosis, HARP syndrome
Lysosomal enzyme panelGangliosidoses, MLD
Very long chain fatty acidsAdrenoleukodystrophy
Urine amino acids + organic acidsOrganic acidaemias (glutaric, methylmalonic)
Arylsulfatase AMLD
Filipin staining / NPC1 geneNiemann-Pick C
HPRT enzymeLesch-Nyhan
Uric acidLesch-Nyhan
Lactate, pyruvateMitochondrial disease

Step 3: Genetic Testing

Gene PanelWhen
DYT1 (TOR1A) deletionYoung-onset generalised, no secondary cause found
DYT6 (THAP1)Adolescent onset, prominent cervical/laryngeal involvement
GCH1 (DRD)If levodopa trial response uncertain
PANK2"Eye of tiger" on MRI
ATP7BWilson disease confirmation
Whole exome sequencingIf targeted panel negative

Treatment

Step 1: Levodopa Trial — ALWAYS FIRST

  • Start 50–100 mg levodopa/day, titrate
  • DRD: dramatic sustained response at low doses — diagnostic and therapeutic
  • Even DYT1 patients may have partial response

Step 2: Oral Medications

DrugMechanismUse
Trihexyphenidyl (anticholinergic)Blocks muscarinic receptorsHigh-dose (up to 20–30 mg/day in young) — most effective for primary generalised dystonia
BaclofenGABA-B agonistAdjunct; intrathecal baclofen for severe cases
ClonazepamGABAergicAdjunct
TetrabenazineDopamine depleterFor hyperkinetic component
ValproateGABAergicAdjunct
D-penicillamine / Trientine / ZincCopper chelationWilson disease — specific treatment
Biotin + ThiamineCofactor replacementBBGD

Step 3: Deep Brain Stimulation (DBS)

  • Globus pallidus interna (GPi) stimulation — treatment of choice for medically refractory primary generalised dystonia
  • Most effective in DYT1 (TOR1A mutation) — 50–90% improvement in BFMDRS
  • Less effective in secondary dystonias
  • Consider after adequate trial of medical therapy

Most Important Teaching Points

  1. A levodopa trial is mandatory in every young-onset generalised dystonia — DRD is treatable and mimics all other forms
  2. Wilson disease must be excluded urgently — it is the most common treatable secondary cause in this age group
  3. MRI with SWI/T2 — look for "eye of the tiger" (PKAN) and Wilson changes (putaminal T2 changes, "face of panda")
  4. Adolescent-onset generalised → DYT1 (TOR1A) is most likely primary cause if secondary workup negative
  5. GPi-DBS is the most effective intervention for medication-refractory primary generalised dystonia

Sources: Localization in Clinical Neurology 8e; Adams & Victor's Principles of Neurology 12e; Harrison's Principles of Internal Medicine 22E

Amoebic meningoencephalitis

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Loading Image
Comprehensive data collected. Here is the full structured review:

Amoebic Meningoencephalitis

Overview

Four genera of free-living environmental amoebae — not requiring a human host — can cause CNS infection:
GenusCNS Syndrome
Naegleria fowleriPrimary Amoebic Meningoencephalitis (PAM)
Acanthamoeba spp.Granulomatous Amoebic Encephalitis (GAE) + Keratitis
Balamuthia mandrillarisGranulomatous Amoebic Encephalitis (GAE)
Sappinia pedataGAE (single case reported)

1. PRIMARY AMOEBIC MENINGOENCEPHALITIS (PAM)

Caused by Naegleria fowleri

Organism

  • Thermophilic free-living amoeba; thrives in warm freshwater (lakes, rivers, poorly maintained pools, neti pots, waterslides)
  • Exists in three forms: trophozoite (amoeboid) → flagellate (transient, non-feeding) → cyst
  • Only trophozoite is pathogenic

Epidemiology

  • Worldwide; ~381 cases globally through 2022; 0–8 cases/year in USA
  • 75% male; median age 14 years (range 1 month–85 years)
  • 91% had recreational freshwater exposure
  • Cases rising in northern US states (climate change)
  • Prevalence ~2.6 cases per million exposures

Pathogenesis

Warm freshwater inhaled nasally
        ↓
Trophozoites enter olfactory neuroepithelium
        ↓
Migrate along olfactory nerve → cribriform plate
        ↓
Enter CNS, bypass blood-brain barrier
        ↓
Fulminant necrotizing hemorrhagic encephalitis
        ↓
Neutrophilic response — olfactory bulbs/frontal lobes first
        ↓
Diffuse cerebral edema, uncal herniation → death (median <10 days)

Clinical Features

FeatureDetails
Incubation2–15 days
FeverHigh, universal
HeadacheSevere
Nausea/vomitingPresent early
MeningismusUsually present (mimics bacterial meningitis)
PhotophobiaCommon
CN III, IV, VI palsiesFrequent
SeizuresProgressive
ComaRapid progression
Uncal herniationTerminal event
Death~10 days from exposure; mortality >97%

CSF Findings

ParameterResult
Opening pressureElevated
AppearanceHaemorrhagic / purulent
WBCHigh — neutrophilic (up to 20,000/µL)
ProteinElevated
GlucoseLow
Gram stain / cultureNegative for bacteria
Wet mountMotile trophozoitesdiagnostic
Critical: CSF must be examined immediately as a fresh wet preparation — trophozoites are motile and die if refrigerated. This is the bedside diagnostic.

Diagnosis

TestNotes
Fresh CSF wet mountMotile trophozoites (10–35 µm) — diagnostic
CDC PCRMost sensitive; call CDC (770-488-7100)
Histochemical staining of biopsyAvailable via CDC
MRIObliteration of cisterns, diffuse enhancement; olfactory bulb involvement
SerologyNot useful — antibodies found in healthy adults

Treatment (Medical Emergency)

All 7 worldwide survivors received this combination:
DrugRole
Miltefosine (Impavido)Central — all survivors received this; alkylphosphocholine; crosses BBB
Liposomal Amphotericin B (IV + intrathecal)Primary amoebicidal
FluconazoleSynergistic
AzithromycinSynergistic
RifampinSynergistic
DexamethasoneNeuroinflammation / cerebral edema
Therapeutic hypothermiaAssociated with survival
Contact CDC Emergency Operations: (770) 488-7100 — for miltefosine access and PCR diagnosis

2. GRANULOMATOUS AMOEBIC ENCEPHALITIS (GAE)

Caused by Acanthamoeba spp. and Balamuthia mandrillaris

These two share the GAE syndrome but differ in key ways:

Comparison: Acanthamoeba vs Balamuthia

FeatureAcanthamoebaBalamuthia mandrillaris
HostUsually immunocompromisedCan affect immunocompetent
Risk factorsAIDS, transplant, steroids, lymphoma, lupusYoung age, Hispanic ethnicity, soil/water exposure
Entry routeInhalation or skin contact → haematogenousPercutaneous or mucous membrane → haematogenous
OnsetSubacute/chronic (weeks to months)Subacute — weeks to months
Skin lesionsCutaneous ulcers/nodules (especially AIDS)Face/trunk/extremity skin lesions — early clue
CNSMimics space-occupying lesionFocal deficits, seizures, headache, fever
CSFMononuclear pleocytosis; elevated proteinMononuclear or neutrophilic pleocytosis; elevated protein; normal-low glucose
Amoebae in CSFRareRarely isolated
Brain imagingMultiple hypodense/enhancing lesions; mimics toxoplasmosisMultiple hypodense lesions
DiagnosisBiopsy — trophozoites + cysts; culture on E. coli-seeded agarCSF, biopsy; CDC PCR; fluorescent antibody
Transplant transmissionLess documentedYes — 3 clusters 2009–2012
SurvivalVery rare; accelerated course in AIDS/transplant (3–40 days)9 survivors in USA with aggressive treatment
TreatmentMiltefosine + combinationPentamidine + flucytosine + sulfadiazine + macrolides + miltefosine

Acanthamoeba Keratitis (Separate Syndrome)

  • Contact lens wearers (major risk — especially with homemade saline, swimming in lenses)
  • Annular paracentral corneal ring — characteristic sign
  • Irregular polygonal double-walled cysts on corneal scraping (see image below)
  • Treatment: polyhexamethylene biguanide (0.2%) + propamidine isethionate (0.1%) drops; severe cases need keratoplasty
  • Cysts are drug-resistant — difficult to treat

Side-by-Side Comparison: PAM vs GAE

FeaturePAM (Naegleria)GAE (Acanthamoeba / Balamuthia)
OnsetAcute/fulminantSubacute/chronic
HostHealthy, young, maleImmunocompromised (Acanthamoeba); any (Balamuthia)
ExposureWarm freshwater swimming/nasalSkin/soil/air → haematogenous
EntryOlfactory neuroepitheliumHaematogenous from skin/lung/sinus
PathologyNecrotizing haemorrhagic encephalitisGranulomatous encephalitis
CSFNeutrophilic, haemorrhagic, motile trophozoitesMononuclear; organisms rarely seen
MeningismusPresent (like bacterial meningitis)Variable; less prominent
MRIDiffuse oedema, cisternal obliterationMultiple focal lesions (mimic tumour/abscess/toxoplasmosis)
DiagnosisFresh CSF wet mount (motile trophozoites)Brain biopsy (trophozoites + cysts)
CourseDeath in <10 daysWeeks to months
Mortality>97%>95%
Key treatmentMiltefosine + AmB + FLU + AZI + RIF + DexaMiltefosine + organism-specific combinations

Pathological Images

Acanthamoeba castellani double-walled cyst (phase-contrast microscopy) — characteristic irregular polygonal shape:
Acanthamoeba double-walled cyst
Balamuthia mandrillaris GAE — MRI showing large parieto-occipital lesion and smaller satellite lesions:
Balamuthia brain MRI

When to Suspect Each

Young healthy person + warm freshwater swimming + acute meningitis-like illness
→ PAM (Naegleria) — CSF wet mount STAT

Immunocompromised + subacute focal brain lesions + skin nodules/ulcers
→ GAE (Acanthamoeba) — brain biopsy

Immunocompetent or immunocompromised + skin lesion on face + subacute encephalopathy
+ soil/water exposure or organ transplant recipient
→ GAE (Balamuthia) — CDC PCR + biopsy

Contact lens wearer + painful red eye + annular corneal ring
→ Acanthamoeba keratitis — corneal scraping for cysts

Key Points for Exams

  1. PAM = olfactory route (Naegleria); GAE = haematogenous route (Acanthamoeba, Balamuthia)
  2. PAM mimics bacterial meningitis; GAE mimics brain tumour or toxoplasmosis
  3. Diagnosis of PAM: motile trophozoites on fresh CSF wet mount (never refrigerate)
  4. Miltefosine is the most important drug for all three — included in all 7 PAM survivors
  5. Serology is not useful for PAM (antibodies found in healthy adults)
  6. Acanthamoeba keratitis: contact lens wearers; cysts resist treatment — high recurrence
  7. Balamuthia is the only free-living amoeba that regularly causes GAE in immunocompetent individuals
Sources: Harrison's Principles of Internal Medicine 22E; Robbins & Kumar Basic Pathology; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Medical Microbiology 9e; Tintinalli's Emergency Medicine

Hypertrophic olivary degeneration

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Searching PubMed

"hypertrophic olivary degeneration" MRI clinical

Finding Sources
Finding Sources
Reading File
Reading Article

PMID: 31026459

Searching Images

hypertrophic olivary degeneration MRI inferior olive T2

Finding Sources
Loading Image
Loading Image
Excellent images obtained. Here is the comprehensive review:

Hypertrophic Olivary Degeneration (HOD)

Definition

Hypertrophic Olivary Degeneration (HOD) is a rare form of trans-synaptic (transaxonal) degeneration of the inferior olivary nucleus (ION) in the medulla oblongata, occurring secondary to lesions disrupting the Guillain-Mollaret triangle (GMT).
Unlike most degenerative processes where neurons atrophy and shrink, the ION paradoxically enlarges — hence "hypertrophic" rather than atrophic degeneration. This is because the dominant pathological process is astrocytic hypertrophy and vacuolation of olivary neurons, not simple neuronal loss.
First described by Oppenheim in post-mortem studies; the enlarged ION was first correlated with clinical palatal myoclonus by Guillain and Mollaret.

The Guillain-Mollaret Triangle (GMT) — The Anatomical Key

HOD results from disruption of this three-cornered circuit:
          MIDBRAIN
    Red Nucleus (ipsilateral)
          /         \
Central Tegmental    Brachium Conjunctivum
    Tract (CTT)      (Superior Cerebellar Peduncle)
         ↓                    ↑
    MEDULLA               CEREBELLUM
Inferior Olivary         Dentate Nucleus
  Nucleus (ION)          (contralateral)
    (ipsilateral)
         ↓ __________________|
    Inferior Cerebellar
    Peduncle (climbing fibers)

Three limbs of the triangle:

LimbPathwayDirection
1. Central Tegmental Tract (CTT)Red nucleus → Inferior oliveDescending (ipsilateral)
2. Superior Cerebellar PeduncleDentate nucleus → Red nucleusAscending (crosses at midbrain)
3. Inferior Cerebellar PeduncleInferior olive → Dentate nucleus (climbing fibers)Ascending (crosses)
Lesion anywhere in the GMT → ION disinhibition → olivary pseudohypertrophy

Pathophysiology

Why Does the Olive Enlarge (Not Atrophy)?

When the CTT or the dentato-rubro pathway is disrupted:
  1. Deafferentation of the ION from its inhibitory inputs
  2. ION neurons undergo vacuolar change and astrocytic hypertrophy (not neuronal loss initially)
  3. Gap junctions between olivary neurons become upregulated → rhythmic synchronized discharges
  4. These discharges propagate via climbing fibers → cerebellar cortex → palatal muscles → palatal tremor
  5. Over months to years → eventual neuronal loss and olivary atrophy (late stage)

Timeline of MRI Changes

Time from lesionMRI finding
0–1 monthNo olivary change (normal MRI)
1–6 monthsT2 hyperintensity appears in ION (earliest sign)
6 months–3–4 yearsT2 hyperintensity + enlargement of ION (classic HOD)
>3–4 yearsEnlargement resolves; T2 hyperintensity may persist or also regress
The latency of months between the causative lesion and onset of palatal tremor / MRI changes is a hallmark of HOD.

Causes of HOD — Lesions Disrupting the GMT

Most Common

CauseNotes
Brainstem infarction (most common)CTT in pons/midbrain; posterior circulation strokes
Brainstem haemorrhagePontine haemorrhage is the most common single cause
Cerebellar infarction/haemorrhageDentate nucleus involvement
Neurosurgical proceduresPosterior fossa surgery; tumour resection
TumoursBrainstem glioma, metastases, cavernomas
DemyelinationMS plaques in CTT
TraumaDiffuse axonal injury

Less Common

  • Cavernous malformation (haemosiderin deposition in GMT)
  • Arteriovenous malformation
  • Radiation injury
  • Metabolic/toxic (e.g., Wernicke encephalopathy affecting midbrain)

Unilateral vs Bilateral HOD

This depends on which limb of the GMT is affected:
Lesion SiteHOD LateralityExplanation
Unilateral CTT (pons/midbrain)Contralateral ION hypertrophyCTT descends ipsilaterally to the olive; olive projects contralaterally to the dentate; the "disinhibited" side is contralateral to the CTT lesion
Unilateral dentate nucleusIpsilateral ION hypertrophyDentato-rubro-olivary pathway
Both CTT + dentate nucleus (or crossing fibres)Bilateral HODMore complex lesions
Rule: With unilateral palatal tremor, the contralateral olive enlarges. — Adams & Victor's Neurology 12e

Clinical Features

Cardinal Feature: Symptomatic Palatal Tremor

  • Rhythmic, 1–3 Hz contractions of the levator veli palatini (CN X)
  • Persists during sleep (unlike essential palatal tremor)
  • No auditory click (unlike essential palatal tremor)
  • Onset: typically months after the causative lesion

Other Oculomotor Features

  • Pendular nystagmus (synchronised with palatal movements)
  • Oculopalatal myoclonus:
    • Unilateral lesion: jerky, nystagmoid, oblique/rotatory eye movements
    • Bilateral lesion: vertical to-and-fro pendular nystagmus

Other Movements

  • Rhythmic contractions of pharynx, facial muscles, diaphragm, vocal cords, neck/shoulders
  • Dentatorubral tremor — limb tremor from dentate/rubral involvement
  • Cerebellar ataxia (from the primary lesion)

Neurological Deficits from Primary Lesion

  • Hemiparesis, dysarthria, dysphagia — depending on brainstem lesion location

MRI Findings — The Diagnostic Signature

T2/FLAIR: Hyperintensity + enlargement of the inferior olivary nucleus in the medulla
T1: Hypointense (no enhancement with gadolinium — distinguishes from tumour)
No gadolinium enhancement — important to differentiate from:
  • Brainstem neoplasm
  • Demyelinating plaque
  • Inflammatory lesion

Classic MRI Appearance:

HOD on T2 MRI — bilateral inferior olive hyperintensity and enlargement (red arrows):
HOD T2 and FLAIR bilateral
HOD axial and coronal T2 — unilateral enlargement of inferior olive (black arrows):
HOD axial and coronal T2

Differential Diagnosis of Inferior Olive T2 Signal

ConditionKey Differentiator
HODNo enhancement; enlarged; delayed onset after GMT lesion; palatal tremor
Brainstem tumourEnhancement; mass effect; no latency
Demyelinating plaque (MS)Other white matter lesions; may enhance acutely
Wernicke encephalopathyMammillary bodies + periaqueductal gray + thalamus also involved
Osmotic demyelinationPons centrally; history of hyponatraemia correction
Brainstem infarction (acute)DWI restriction; acute onset

HOD vs Essential Palatal Tremor — Quick Recap

Symptomatic Palatal Tremor (= HOD)Essential Palatal Tremor
MuscleLevator veli palatiniTensor veli palatini
Ear click❌ No✅ Yes
SleepPersistsDisappears
MRI oliveEnlarged + T2 brightNormal
GMT lesion✅ Present❌ None
Onset after lesionMonthsNo prior lesion

Treatment

InterventionNotes
GabapentinMost effective (dramatic in some)
Clonazepam0.25–6 mg/day
Sodium valproate250–1000 mg/day
MemantineReported benefit (NMDA receptor modulation of olivary rhythmicity)
Botulinum toxinPalatal injection — modest relief
Treat primary lesionIf vascular, manage risk factors
No cureHOD itself is irreversible once established

Summary

HOD = trans-synaptic degeneration of the inferior olive, occurring months after a lesion interrupts the Guillain-Mollaret triangle (red nucleus → central tegmental tract → inferior olive → dentate nucleus → back)
MRI: T2/FLAIR hyperintensity + enlargement of ION, no gadolinium enhancement, delayed onset 1–6 months after causative lesion
Clinically: Symptomatic palatal tremor + pendular nystagmus ± rhythmic myoclonus of face/pharynx/diaphragm
Key concept: The olive hypertrophies (not atrophies) because the process is astrocytic vacuolation and gap junction upregulation — not simple neuronal loss
Sources: Adams & Victor's Principles of Neurology 12e; Localization in Clinical Neurology 8e; Wang et al. Brain Research 2019 [PMID 31026459]

How to ask for history in dementia for all lobes

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have sufficient data from Harrison's and Localization in Clinical Neurology to give a comprehensive, clinically structured answer. Here it is:

Taking History in Dementia — Lobe by Lobe

Principle

Each cerebral lobe subserves specific cognitive functions. When taking a history in dementia, you systematically ask questions that probe each lobe's function — mapping the pattern of deficits to the anatomical distribution of disease. This tells you not just that the patient has dementia, but what type, and guides investigation and management.
Always obtain history from both patient AND a reliable informant (caregiver/family) — the patient may lack insight (anosognosia), especially in frontal or parietal disease.

Framework: What Each Lobe Does and What to Ask


🔵 FRONTAL LOBE

Functions: Executive function, working memory, planning, sequencing, abstract reasoning, impulse control, personality, social behaviour, motor speech (Broca's area — dominant), motor cortex

Questions to Ask:

Executive / Planning:
  • "Has he/she become disorganised? Does he/she struggle to plan a meal, manage money, or pay bills?"
  • "Can he/she do tasks in the right order — like making tea (fill kettle, boil, pour)?"
  • "Does he/she start tasks but not finish them?"
  • "Can he/she switch between tasks, or does he/she get stuck on one thing?"
Behaviour / Personality Change:
  • "Has his/her personality changed? Is he/she a different person from before?"
  • "Has he/she become disinhibited — saying rude or inappropriate things, making sexual remarks, or behaving badly in public?"
  • "Is he/she impulsive — spending money recklessly, grabbing food off others' plates?"
  • "Has he/she lost social awareness — does he/she embarrass the family?"
Apathy:
  • "Has he/she become very passive, lost initiative, stopped doing things he/she used to enjoy?"
  • "Does he/she sit all day without doing anything unless prompted?"
  • "Is there poverty of speech — speaking very little spontaneously?"
Compulsive / Stereotyped Behaviour:
  • "Does he/she repeat the same actions or phrases over and over?"
  • "Does he/she have rigid routines — insisting on eating the same food or following the same route?"
Hyperorality:
  • "Does he/she put objects in the mouth? Eat excessively or indiscriminately?"
Motor Speech (Broca's / Non-fluent Aphasia):
  • "Has his/her speech become halting, effortful, or telegraphic (short sentences)?"
  • "Does he/she struggle to get words out even though he/she seems to know what to say?"
Suggests: Frontotemporal dementia (bvFTD), non-fluent/agrammatic PPA, PSP, CBD

🟠 TEMPORAL LOBE

Functions: Episodic memory (medial temporal — hippocampus), semantic memory (anterior temporal), language comprehension (Wernicke's — dominant), face and object recognition, auditory processing, emotion (amygdala)

Questions to Ask:

Episodic Memory (Hippocampus / Medial Temporal):
  • "Does he/she repeat the same questions or stories within minutes — not realising they've already said it?"
  • "Does he/she forget recent events — what happened yesterday, what he/she had for breakfast?"
  • "Does he/she remember remote events (childhood, old friends) better than recent ones?"
  • "Does he/she forget appointments, miss medications, forget names of recent acquaintances?"
  • "Does he/she get lost in familiar places — e.g., going to the local shop?"
Semantic Memory (Anterior Temporal):
  • "Has he/she lost knowledge of objects — not recognising what a 'kettle' or 'umbrella' is?"
  • "Has he/she lost word meanings — uses words incorrectly or says 'that thing' instead of the name?"
  • "Does he/she fail to recognise faces of famous people (e.g., politicians)?"
Language Comprehension (Wernicke's — dominant temporal):
  • "Does he/she have difficulty understanding what is said to him/her?"
  • "Does he/she give nonsensical answers to questions — as if talking about something different?"
  • "Is his/her speech fluent but empty — lots of words but no meaning?"
Prosopagnosia (Face Recognition — non-dominant):
  • "Does he/she fail to recognise familiar faces — even close family members?"
Auditory/Musical:
  • "Any change in appreciation of music or sounds?"
Suggests: Alzheimer's disease (medial temporal first), LATE, semantic variant PPA (anterior temporal), Wernicke's aphasia in PPA

🟡 PARIETAL LOBE

Functions: Visuospatial processing (non-dominant), attention (bilateral), calculation, writing, reading (dominant), praxis (dominant — left), sensory integration, body schema

Questions to Ask:

Visuospatial (Non-dominant — Right Parietal):
  • "Does he/she get lost in familiar places — his/her own house, or the route to the local shop or temple?"
  • "Does he/she have difficulty parking the car, judging distances, or navigating in a mall?"
  • "Does he/she bump into furniture or objects on one side?"
  • "Does he/she have difficulty recognising objects or faces even with normal vision?"
Apraxia (Dominant — Left Parietal):
  • "Has he/she lost the ability to use everyday tools correctly — using a toothbrush, a key, a fork, a lighter?"
  • "Has he/she become clumsy with buttons, zips, or shoelaces?"
  • "Does he/she have difficulty imitating gestures (e.g., waving goodbye)?"
Acalculia / Agraphia / Alexia (Dominant):
  • "Can he/she still manage money — count change, do simple arithmetic?"
  • "Has his/her writing become abnormal?"
  • "Can he/she still read — newspaper, messages?"
Gerstmann Syndrome (Dominant Angular Gyrus: agraphia + acalculia + finger agnosia + left-right disorientation):
  • "Does he/she confuse left and right?"
  • "Can he/she identify individual fingers?"
Neglect (Non-dominant Parietal):
  • "Does he/she ignore one side of the body or environment — only eating food from one side of the plate? Only shaving/grooming one side of the face?"
Dressing Apraxia (Non-dominant):
  • "Does he/she have difficulty dressing — putting clothes on the wrong way, inability to work out how garments go on?"
Suggests: Posterior cortical atrophy (PCA — Alzheimer's variant), corticobasal degeneration, DLB (posterior parietal)

🟢 OCCIPITAL LOBE

Functions: Primary visual processing, visual recognition, colour, motion perception

Questions to Ask:

Visual Hallucinations:
  • "Does he/she see things that are not there — people, animals, patterns?"
  • "How vivid are they? Are they frightening or not?"
  • "Do they occur in low light conditions?"
Visual Object Agnosia:
  • "Can he/she recognise objects just by looking at them (with normal vision)?"
  • "Does he/she mistake objects for other things?"
Colour / Motion:
  • "Any difficulty recognising colours or perceiving moving objects?"
Cortical Blindness / Anton Syndrome:
  • "Is he/she unaware of being blind — denying the visual problem even when it is obvious?"
Suggests: DLB (vivid visual hallucinations), posterior cortical atrophy, CJD, occipital strokes

⚫ LIMBIC / CINGULATE

Functions: Emotion, motivation, mood, social cognition

Questions to Ask:

  • "Has he/she become emotionally flat — no joy, no sadness?"
  • "Is he/she socially withdrawn, no longer interested in family or friends?"
  • "Is he/she irritable, anxious, or depressed — a new change from baseline?"

⚪ SUBCORTICAL / WHITE MATTER

Functions: Processing speed, attention, working memory, motor coordination

Questions to Ask:

  • "Has he/she slowed down mentally — takes much longer to answer questions or complete tasks?"
  • "Is there forgetfulness that improves with prompting (subcortical — unlike cortical where cueing doesn't help)?"
  • "Has there been change in gait — shuffling, falls, urinary incontinence (NPH triad)?"
Suggests: Vascular dementia, Binswanger's, NPH, Huntington's, PSP

Putting It Together: Pattern Recognition

Predominant LobeEarliest SymptomsCommon Diagnosis
Medial temporalEpisodic memory loss, repetitionAlzheimer's disease, LATE
FrontalPersonality, behaviour, disinhibition, apathyFTD (bvFTD), PSP
Dominant temporal (anterior)Word meaning loss, fluent empty speechSemantic PPA
Dominant temporal (posterior)Comprehension failure, fluent paraphasiaWernicke's/logopenic PPA
Dominant frontalEffortful, halting speechNon-fluent PPA, CBS
Parietal + occipitalVisuospatial, apraxia, visual hallucinationsPCA, DLB, CBS
Subcortical + frontalSlowing, gait, incontinenceVascular, NPH
Multifocal/rapidAny combination + rapid progressionCJD, autoimmune encephalitis

Additional Screening History (Always Ask)

DomainQuestions
OnsetSudden (vascular) vs gradual (degenerative) vs fluctuating (DLB)
CourseProgressive / stepwise (vascular) / relapsing
ADLsDressing, bathing, cooking, driving, finances, medications
SleepREM sleep behaviour disorder (punching/kicking in sleep) → DLB/PD
FallsRepeated early falls → PSP
HallucinationsVisual hallucinations early → DLB
DrugsAnticholinergics, benzodiazepines, opioids
Risk factorsHypertension, diabetes, smoking (vascular), family history
MoodDepression can mimic and worsen dementia
Occupational historyToxic exposures; head trauma (CTE)

Memory Aid: "FLPOT" — 5 Lobes × Signature Symptoms

LobeSignature Question
Frontal"Has his personality changed? Does he do inappropriate things?"
Limbic/Temporal"Does he repeat the same question within minutes?"
Parietal"Does he get lost in familiar places? Can he still dress himself?"
Occipital"Does he see things that aren't there?"
Temporal (semantic)"Has he lost the meaning of words? Does he recognise familiar faces?"
Sources: Harrison's Principles of Internal Medicine 22E (Table 33-4, Functional Anatomy of Dementias); Localization in Clinical Neurology 8e; Adams & Victor's Principles of Neurology 12e

Dystonia

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.